These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Commentary on the published results of the Lipid Research Clinics Coronary Primary Prevention Trial. Kronmal RA JAMA; 1985 Apr; 253(14):2091-3. PubMed ID: 3883022 [No Abstract] [Full Text] [Related]
7. [Treatment of high blood cholesterol in patients with coronary heart disease]. Nagai Y; Yamashita S Nihon Rinsho; 2003 Apr; 61 Suppl 4():675-81. PubMed ID: 12735049 [No Abstract] [Full Text] [Related]
8. Management of hypercholesterolaemia and cholestyramine. Nye ER; Scott PJ; Janus ED N Z Med J; 1984 Apr; 97(754):272. PubMed ID: 6587212 [No Abstract] [Full Text] [Related]
9. The lipid hypothesis is proven. Simons LA Med J Aust; 1984 Mar; 140(6):316-7. PubMed ID: 6366488 [No Abstract] [Full Text] [Related]
11. A study of the dose-effect relationship of cholestyramine in children with familial hypercholesterolemia. Farah JR; Kwiterovich PO; Neill CA Adv Exp Med Biol; 1977; 82():212-5. PubMed ID: 200092 [No Abstract] [Full Text] [Related]
12. Hyperlipidaemia, smoking and hypertension. The place of the hyperlipidaemias. Lloyd JK; West RJ Postgrad Med J; 1978 Mar; 54(629):190-6. PubMed ID: 206883 [TBL] [Abstract][Full Text] [Related]
13. [Significance of hypercholesterolemia for epidemiology, prevention and pathogenesis of coronary heart diseases]. Gohlke H Dtsch Med Wochenschr; 1989 Dec; 114(50):1974-8. PubMed ID: 2689125 [No Abstract] [Full Text] [Related]
14. Primary prevention of coronary heart disease with drug therapy. Safety and total mortality issues. Grundy SM Arch Intern Med; 1992 Jul; 152(7):1369-71. PubMed ID: 1627015 [No Abstract] [Full Text] [Related]
15. [The cholesterol question. Disinformed information]. Bobbio M; Brusca A G Ital Cardiol; 1991 Sep; 21(9):1029-33. PubMed ID: 1790828 [No Abstract] [Full Text] [Related]
16. The Lipid Research Clinics Coronary Primary Prevention Trial: results and implications. Rifkind BM Monogr Atheroscler; 1985; 13():74-84. PubMed ID: 3911061 [No Abstract] [Full Text] [Related]
17. Should hyperlipoproteinemia be treated in patients with coronary artery disease? Rider AK JAMA; 1975 Jul; 233(3):275-7. PubMed ID: 168412 [No Abstract] [Full Text] [Related]
18. [Hypolipidemic effect of cholestyramine in patients affected by type II hyperlipoproteinemia]. Sauvanet JP; Drouin P; Mejean L; Lambert D; Debry G Therapie; 1978; 33(5):615-22. PubMed ID: 217121 [No Abstract] [Full Text] [Related]
19. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia. Orö L; Olsson AG; Rössner S; Carlson LA Postgrad Med J; 1975; 51(8):76-81. PubMed ID: 176639 [No Abstract] [Full Text] [Related]
20. [On the treatment of hyperlipoproteinaemia type II with cholestyramine (author's transl)]. Válek J; Pechar J; Hrubá F Cas Lek Cesk; 1973 Dec; 112(49):1531-4. PubMed ID: 4358602 [No Abstract] [Full Text] [Related] [Next] [New Search]